A Canadian Study to Assess the Safety of Humate-P® Ivr (Infusion Volume Reduced)
NCT00701545
·
clinicaltrials.gov ↗
COMPLETED
Status
21
Enrollment
INDUSTRY
Sponsor class
Conditions
Von Willebrand Disease
Sponsor
CSL Behring